Cargando…

Hairy cell leukemia expresses programmed death-1

Detalles Bibliográficos
Autores principales:	Kumar, Priyadarshini, Gao, Qi, Chan, Alexander, Lewis, Natasha, Sigler, Allison, Pichardo, Janine, Xiao, Wenbin, Roshal, Mikhail, Dogan, Ahmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644662/ https://www.ncbi.nlm.nih.gov/pubmed/33154356 http://dx.doi.org/10.1038/s41408-020-00384-1

Ejemplares similares

Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma
por: Yabe, Mariko, et al.
Publicado: (2020)

Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms
por: Gao, Qi, et al.
Publicado: (2018)

Reduced Plasmacytoid Dendritic Cell Output Is Associated With High Risk in Low-grade Myelodysplastic Syndrome
por: Chan, Alexander, et al.
Publicado: (2022)

Low‐dose vemurafenib in hairy cell leukemia patients with active infection
por: Bohn, Jan‐Paul, et al.
Publicado: (2019)

The t(11;14)(q13;q32)/CCND1–IGH translocation in chronic lymphocytic leukaemia/small lymphocytic lymphoma: an unusual genetic aberration during the natural clinical course
por: Liu, Ying, et al.
Publicado: (2019)

Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of BRAF V600E Testing in Diagnosis and Treatment
por: Soong, Deborah, et al.
Publicado: (2021)

Molecular Genetic Analysis With Flow Cytometry Sorting Identifies Angioimmunoblastic T-Cell Lymphoma and Concomitant De Novo Myelodysplastic Syndrome Arising From the Same Hematopoietic Progenitor
por: Naganuma, Ken, et al.
Publicado: (2020)

Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients
por: Zheng, Guoqiao, et al.
Publicado: (2019)

Single‐center study of outcomes of patients with hairy cell leukemia who contracted SARS‐CoV‐2
por: Annunzio, Kaitlin, et al.
Publicado: (2023)

Genomics of Hairy Cell Leukemia
por: Tiacci, Enrico, et al.
Publicado: (2017)

Genetic basis for iMCD-TAFRO
por: Yoshimi, Akihide, et al.
Publicado: (2020)

Myeloid/lymphoid neoplasms with eosinophilia/basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition
por: Yao, Jinjuan, et al.
Publicado: (2020)

Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
por: Maitre, Elsa, et al.
Publicado: (2022)

Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients
por: Maitre, Elsa, et al.
Publicado: (2022)

BRAF Mutation in Hairy Cell Leukemia
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2014)

Hairy cell leukemia – immunotargets and therapies
por: Basheer, Faisal, et al.
Publicado: (2014)

Skeletal involvement of hairy cell leukemia
por: Durot, Eric, et al.
Publicado: (2018)

Time to Cure Hairy Cell Leukemia
por: Levy, Ilana, et al.
Publicado: (2017)

An Unusual Presentation of Hairy Cell Leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2019)

Variant form of hairy cell leukemia
por: Wiber, Margaux, et al.
Publicado: (2019)

Skin changes in hairy cell leukemia
por: Robak, Ewa, et al.
Publicado: (2020)

The Biology of Classic Hairy Cell Leukemia
por: Bohn, Jan-Paul, et al.
Publicado: (2021)

Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders
por: Maitre, Elsa, et al.
Publicado: (2022)

Simultaneous Presentation of Hairy Cell Leukemia and Acute Lymphoblastic Leukemia
por: Li, Mingyong, et al.
Publicado: (2021)

Laparoscopic Splenectomy for Hairy Cell Leukemia in Pregnancy
por: Adeniji, Beni Adegoke, et al.
Publicado: (2010)

A Unique Hairy Cell Leukemia Variant
por: Jian, Charles, et al.
Publicado: (2016)

Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy
por: Shackleton, Louisa, et al.
Publicado: (2019)

Development of Recombinant Immunotoxins for Hairy Cell Leukemia
por: Kreitman, Robert J., et al.
Publicado: (2020)

Disseminated Histoplasmosis with Concurrent Hairy Cell Leukemia
por: Khan, Abdul Moiz, et al.
Publicado: (2020)

Patients with relapsed/refractory hairy‐cell leukemia
por: Paillassa, Jérôme, et al.
Publicado: (2021)

Hairy Cell Leukemia: Where Are We in 2023?
por: Mendez-Hernandez, Andres, et al.
Publicado: (2023)

Hairy cell leukemia with isolated bone lesions
por: Cailly, Laura, et al.
Publicado: (2023)

Asciminib in chronic myeloid leukemia: many questions still remain to be answered
por: Eşkazan, Ahmet Emre
Publicado: (2021)

A common signalosome for programmed cell death in humans and plants
por: Martínez-Fábregas, J, et al.
Publicado: (2014)

Hairy Cell Leukemia Treatment: Where We Are Now?
por: Krstevska, Svetlana, et al.
Publicado: (2011)

Two Cases of Q-Fever in Hairy Cell Leukemia
por: Ammatuna, Emanuele, et al.
Publicado: (2014)

Current and emerging treatment options for hairy cell leukemia
por: López-Rubio, Montserrat, et al.
Publicado: (2015)

Hairy cell leukemia variant: the importance of differential diagnosis
por: Rudolf-Oliveira, Renata Cristina Messores, et al.
Publicado: (2015)

Toxoplasmic Encephalitis with Untreated Hairy Cell Leukemia Variant
por: Ikebe, Taichi, et al.
Publicado: (2016)

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
por: Kreitman, Robert J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aa0j577fj7iguve43h02g5p01c